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CDiscrete event simulation (DES) is a form of computer-based modeling
that provides an intuitive and flexible approach to representing com-
plex systems. It has been used in a wide range of health care applica-
tions. Most early applications involved analyses of systems with con-
strained resources, where the general aim was to improve the
organization of delivered services. More recently, DES has increasingly
been applied to evaluate specific technologies in the context of health
technology assessment. The aim of this article was to provide consen-
sus-based guidelines on the application of DES in a health care setting,
covering the range of issues to which DES can be applied. The articlettp://dx.doi.org/10.1016/j.jval.2012.04.013
general comment. A second group of experts was invited to for-evelopment, parameter estimation, model implementation, model
nalysis, and representation and reporting. For each stage, a brief de-
cription is provided, followed by consideration of issues that are of
articular relevance to the application of DES in a health care setting.
ach section contains a number of best practice recommendations that
ere iterated among the authors, as well as among thewidermodeling
ask force.
eywords: discrete event simulation, best practices, modeling, meth-
ds.
opyright © 2012, International Society for Pharmacoeconomics and
works through the different stages of the modeling process: structural Outcomes Research (ISPOR). Published by Elsevier Inc.
Background to The Task Force
A new Good Research Practices in Modeling Task Force was ap-
proved by the ISPOR Board of Directors in 2010, and the Society
for Medical Decision Making was invited to join the effort. The
Task Force cochairs andmembers are expert developers and ex-
perienced model users from academia, industry, and govern-
ment, with representation from many countries. Several tele-
conferences and hosted information sessions during scientific
meetings of the Societies culminated in an in-person meeting of
the Task Force as a whole, held in Boston in March 2011. Draft
recommendations were discussed and subsequently edited and
circulated to the Task Force members in the form of a survey
where each onewas asked to agree or disagree with each recom-
mendation, and if the latter, to provide the reasons. Each group
received the results of the survey and endeavored to address all
issues. The final drafts of the seven articles were available on the
ISPOR and Society for Medical Decision Making Web sites for
mally review the articles. The comments received were ad-
dressed, and the final version of each article was prepared. (A
copy of the original draft article, as well as the reviewer com-
ments and author responses, is available at the ISPOR Web site:
http://www.ispor.org/workpaper/Modeling-Using-Discrete-Event-
Simulation.asp.) A summary of these articles was presented at a
plenary session at the ISPOR 16th Annual International Meeting
in Baltimore, MD, in May 2011, and again at the 33rd Annual
Meeting of the Society for Medical Decision Making in Chicago,
IL, in October 2011. These articles are jointly published in the
Societies’ respective journals, Value in Health andMedical Decision
Making. This article summarizes the value of discrete event sim-
ulation (DES) to inform health care decisions and presents guid-
ance on best practices in the application of DES. Other articles in
this series [1–6] describe best practices for conceptualizingmod-
els, building and applying other types of models, addressing un-
certainty, and ensuring transparency and validity. Examples are
cited throughout, without implying endorsement or preemi-
nence of the articles referenced.* Address correspondence to: Jonathan Karnon, School of Population Health and Clinical Practice, University of Adelaide, Level 7, 178
orth Terrace, Adelaide, SA 5005, Australia.
E-mail: jonathan.karnon@adelaide.edu.au.
098-3015/$36.00 – see front matter Copyright © 2012, International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
ublished by Elsevier Inc.
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DES is a flexible modeling method characterized by the ability to
represent complex behavior within, and interactions between in-
dividuals, populations, and their environments [7]. In health care,
this means that events occurring to an individual and how that
individual interacts with others, the health care system, and the
general environment can be modeled simultaneously. The term
“discrete” refers to the fact that DES moves forward in time at
discrete intervals (i.e., themodel jumps from the time of one event
to the time of the next) and that the events are discrete (mutually
exclusive). These factors give DES the flexibility and efficiency to
be used over a very wide range of problems.
DES was developed in the 1960s in industrial engineering and
operations research to help analyze and improve industrial and
business processes. Applications in health care have increased
over the last 40 years [8] and include biologicmodels [9,10], process
redesign and optimization [11–13], geographic allocation of re-
sources [14,15], trial design [16,17], and policy evaluation [18–20].
All DES represent an environment or a system, whichmay be a
specific location (e.g., a hospital) or more generally, a particular
disease in a defined population (e.g., persons with cardiovascular
disease in Australia). A strategy is an alternative policy or config-
uration of the system, where the purpose of the model is to com-
pare strategies to identify the one that best meets the decision-
maker’s criteria.
The core concepts of DES are entities, attributes, events, re-
sources, queues, and time.
Entities are objects that have attributes, experience events, con-
sume resources, and enter queues, over time. In health care mod-
els, they are typically patients, but they can be other people (e.g.,
caregivers) or items such as organs, or even signals (e.g., an e-mail)
that can interact with other entities or the system itself. Entities
can be created at the start or whenever it is appropriate to the
problem (e.g., when a new patient arrives at a clinic, or develops a
disease). The time of relevance to an entity may be a subset of the
simulation time (i.e., individual entities can enter and leave a
model between model start and end times).
Attributes are features specific to each entity that allow it to
carry information (e.g., age, sex, race, health status, past events,
quality of life, and accumulated costs). These values may be used
to determine how an entity responds to a given set of circum-
stances (e.g., timing and type of past events may influence the
likelihood and timing of subsequent events). Attribute valuesmay
bemodified at any time during the simulation, may be aggregated
with those of other entities, or analyzed further outside the sim-
ulation (e.g., to estimate mean cost and effect).
Events are broadly defined as things that can happen to an
entity or the environment. An event can be the occurrence of clin-
ical conditions such as onset of a condition (e.g., stroke), an ad-
verse drug reaction, or progression of a disease to a new stage;
resource use (e.g., admission to hospital); clinical decision (e.g.,
change in dose); or even experiences outside of health care (e.g.,
failure to show up at work). Events can occur, and recur, in any
logical sequence.
A resource is an object that provides a service to an entity. This
may require time. DES represents resource availability at relevant
points in time (e.g., a clinic with three doctors is more likely to see
a patient sooner than a one-doctor clinic). In representing re-
sources, DES can capture spatial factors, such as the number of
available consulting rooms or distance between a ward and an
operating theatre (informing times to and from theatre).
If a resource is “occupied” when an entity needs it, then that
entity must wait, forming a queue. Queues can have a maximum
capacity, and alternative approaches to calling entities from
queues can be defined: first-in-first-out (e.g., a typical waiting
room queue); last-in-first-out, where entities get picked from theback of the queue; or based on some priority (such as emergency
room triage).
A fundamental component of DES is time itself. An explicit
simulation clock (initiated at the start of the model run) keeps
track of time. Referencing this clock makes it possible to track
interim periods (e.g., hospital length of stay, time spent with
symptoms, and survival). The discrete handling of time means
that the model can efficiently advance to the next event time,
without wasting effort in unnecessary interim computations (e.g.,
a patient might have nothing happening for 2 years and then a
myocardial infarction occurs, with ambulance, treatment, stroke,
and other events occurring within minutes).
Other important concepts include interaction, which occurs
whenever an entity competes with another over a resource, and
emergent behavior, which is behavior that is characteristic of the
system as a whole, such as spontaneous overcrowding in emer-
gency rooms because elective surgeries are scheduled only once a
week.
DES can be used to address a wide range of questions [21,22]. It
allows for very flexible time management, events can occur any-
time, without restricting occurrences to fixed time intervals [23].
DES is a particularly good choicewhen patients are subject tomul-
tiple or competing risks because its treatment of time allows for
the optimal use of data describing the time to each event. Al-
though this can be approximated in state transition models by
using very short cycle lengths, this can lead to increased running
times because the model has to check whether each event has
occurred during everymodel cycle. DES is also a good choice when
many patient characteristics must be taken into account, particu-
larly if they change over time; when what happens next depends
on what happened before; when the effects of decisions made
along the way (rather than only at the start) are of interest; and
whenever health care or disease processes involve a series of as-
sociated events (e.g., myocardial infarct to resuscitation to percu-
taneous coronary intervention (PCI) stenting to stroke).
There are two categories of DES applications in health care:
non–constrained-resource [24–26] and constrained-resource
odels [27,28]. Non–constrained-resource models—although un-
sual in other fields that use DES—are required in our field to
ccord with the common structural assumption made in most
ealth economic models today: that all required resources are
vailable as needed, with no capacity limitations. In contrast, con-
trained-resource models incorporate these capacity limitations
xplicitly. They represent indirect interactions between individu-
ls, generally involvingmultiple entities (e.g., patients) competing
or access to resources (e.g., for clinic appointments or donor or-
ans) and waiting in queues. Patients’ demand for particular re-
ources and their priority status in a queue may be influenced by
heir attributes. For such scenarios—the very problems for which
t was developed—DES is clearly an appropriate choice.
DES can also be used to model more complex, direct interac-
ions between individuals (e.g., transmission of disease). This
agent-based modeling [29,30]”—an extension of DES—provides
ore detailed representation of interactions between agents. An
gent is an entity with embedded logic that determines how it
esponds to circumstances (e.g., will intimate interaction be ac-
epted).
The remainder of this article covers design and structuring,
stimation and specification of inputs, implementation, running
nd analyzing, and representation and reporting of DES models.
Structure and Design
DES design starts by defining the system to be represented and
relevant events that can occur. Events need not be restricted to
those that change an entity’s health status; they can represent
events that alter the likelihood of other outcomes (e.g., reperfu-
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823V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 8 2 1 – 8 2 7sion following myocardial infarction). In many cases, disease
course can be represented as an event (e.g., occurrence of relapse
or a bone fracture). Disease course can also involve a continuous
variable (e.g., hemoglobin A1c [HbA1c] level in diabetes). Suchmea-
ures can be represented by using attributes, which can be up-
ated during the simulation [31].
Time from an event (e.g., time since diagnosis) can be specified
s an attribute to facilitate the estimation of costs and quality-of-
ife effects, and may also influence the likelihood of subsequent
vents. The choice of other attributes to be represented is in-
ormed by the events included in the model (e.g., patient charac-
eristics that influence the likelihood, severity, priority ordering,
nd outcomes of the specified events).
Common outcomes for constrained-resource models include
ow times, wait times, throughput, and resource utilization
costs). Changes in these variables may also affect health out-
omes (morbidity and/or mortality) via changes in access to care
nd time to treatment. Given that the objective of health care
ystems is to improve outcomes, such effects are of interest to
ecision makers.
Best practices
IV-1 Discrete event simulation (DES) models should be used when the
problem under study involves constrained or limited resources. DES is
also an attractive option in non-constrained models when there are
interactions between individuals, populations and/or their environ-
ment, when time-to-event is best described stochastically rather than
with fixed time intervals and time dependencies are important, when
individual pathways through the model are influenced by multiple
characteristics of the entity, and when recording individual entity ex-
perience is desirable.
IV-2 Constrained resource models should consider the effect of alterna-
tive strategies on health-related outcomes, and not focus solely on
measures of resource utilization and system capacity. The omission of
health-related outcomes from a model should be justified.
IV-3 The need to model constrained resources should be carefully con-
sidered.
The effects of constrained resources should be modeled if
1. levels of access are altered (e.g., increased referral rates result
in longer waiting times for a particular procedure) and
. time to access has significant effects on costs or outcomes (e.g.,
surgery).
Events forwhich the representation of constrained resources is
relevant should be identified, (i.e., those to which entities may not
have immediate access and for which they queue). Most com-
monly, constrained-resource events are represented in models
that evaluate alternative service pathways, though constrained-
resource events have been used to evaluate alternative health
technologies as well [27,28].
Best practices
IV-4 If downstream decisions can have significant effects on the differ-
ences in costs or outcomes, the model should be structured to facilitate
analyses of alternative downstream decisions.
The conceptualization of the system to be modeled should
identify decision points (e.g., at which treatment decisions are
made). At each decision point, the analyst should consider
whether the probabilities of alternative decisions should be repre-
sented (i.e., the likelihoods of alternative downstream decisions
are parameters to be estimated) or whether the analysis seeks to
evaluate combinations of decisions. The latter is clearly relevant
to evaluating the organization of existing services. It is also poten-
tially relevant to the evaluation of new technologies (e.g., the cost-effectiveness of screening may be greatly affected by the diagnos-
tic and treatment decisions).
Parameter Estimation
DES can incorporate various parameter types, representing dis-
ease course, clinical and administrative decision algorithms,
resource costs and constraints, health condition costs, and
quality-of-life weights. Disease course parameters are com-
monly represented as time-to-event (i.e., the parameter de-
scribes the likelihood of subsequent event(s) occurring at vari-
ous, often continuous, time points). Some disease parameters
may be unobservable (e.g., preclinical disease stages in screen-
ing models requiring calibration for estimation [32]).
Algorithms describe decisions regarding treatment, prioritiz-
ing of patients, and implementation of clinical orders. Costs and
quality-of-life weights are attached to events and time spent with
different health conditions to estimate long-term costs and health
outcomes (e.g., quality-adjusted life-years [QALYs]).
Trade-off between structure and parameter estimation
As DES facilitates complex structures, it often requires extensive
data. There are several optionswhen lacking data for someparam-
eters. Themost radical is to desist from building themodel, which
may be appropriate whenmissing information is extensive. Alter-
natively, the original model structure may be maintained and
missing parameter values derived via calibration. Calibration is
useful even when empirical estimates are available for all inputs,
especially for complex models with many uncertain parameters.
There is not a unique set of inputs, however, that reproduces a set
of calibration targets, and the uncertainty around calibrated pa-
rameter values should be represented in sensitivity analysis [33].
Another option is to eliminate the sections of the model that re-
quire the parameterswithmissing information. This restructuring
requires assessment of whether the revised model can provide
sufficient insight into the problem. Ideally, the importance of the
parameters to be excluded would be assessed by running the orig-
inal model over a credible range of values for those parameters.
The use of expert elicited data as applied to DES
In the absence of data, inputs may be elicited from experts work-
ing in the system modeled. Expert elicitation is subject to a range
of biases, both intentional and unintentional. The strength (or
value) of elicited inputs will vary according to the complexity (or
granularity) of the parameters and the experience of the experts.
To increase confidence in values elicited from experts, it is impor-
tant to validate their responses by asking additional questions
from which elicited values can be compared with empirical data.
For a DES, cliniciansmight be asked to estimate not only themiss-
ing frequency of referrals to another professional but also the em-
pirically estimated frequency of surgical referrals. Their accuracy
in estimating the latter provides some sense of their accuracywith
respect to the unknown parameter. Elicited parameter values can
also be cross-checked by comparing expert values from indepen-
dent sources. It is also important to represent the certainty with
which different parameters can be estimated by experts, forwhich
established methods can be applied that also provide transpar-
ency [34].
Best practices
IV-5 If parameter values are elicited from experts, uncertainty around
the elicited values should be represented, and the elicited values should
be validated.
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824 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 8 2 1 – 8 2 7IV-6 If confidence in the elicited values is low, resulting analysis should
be viewed only as a starting point for what-if analyses, and for esti-
mating the value of collecting additional data.
IV-7 If the decision is made to modify the original structure due to data
constraints, the new structure must be carefully analyzed to under-
stand the effects of modifications so as to inform decision makers of the
additional uncertainty introduced. Explicit considerations of the size
and likely direction of the effects of the modification should be pre-
sented.
Clinical guidelines are not always implemented
DESoften represents clinical andadministrative decision-making al-
gorithms (e.g., processes for assigning patients to clinics). Although
clinical guidelines may specify resources that ought to be available
and thedecisions that cliniciansought tomake, there is considerable
evidence of variation in the uptake of guidelines [35]. Indeed, one of
the purposes of themodelmay be to demonstrate the potential costs
and benefits of adhering to published guidelines. The algorithms
could be derived from analyses of patient records, though it is often
more feasible to ask clinicians and administrators what decisions
they make, given specified circumstances.
Best practices
IV-8 When modeling clinical practice, it should not be assumed that
relevant guidelines are actually applied.
IV-9 Ideally, clinical and administrative decision algorithms should be
based on analyses of observed decisions. If that is infeasible, algo-
rithms should be developed with relevant personnel, and validated
using routinely collected data (e.g., extracting data from patient re-
cords).
Assigning times-to-next-event
When analyzing patient-level data to estimate the time-to-next-
event for two ormore possible next events, competing riskmodels
are not required unless the competing risks (i.e., events that pre-
clude or alter the likelihood of another event occurring) are not
represented in the DES, since a new time-to-event can be sampled
for the events that are not the first to occur. Two approaches to
analyzing time-to-event data are estimating [36].
1. separate times to each potential next event, with the entity
moving to the event with the earliest sampled time, or
. a single time to the next event, with a separate sampling pro-
cess to determine the type of event that occurs (e.g., using
multinomial regression analyses to define the relevant proba-
bilities). The type probabilities may vary as a function of the
sampled time to the next event.
pproach 1) is more straightforward to parameterize: survival data
or each event can be used directly, or parametric curves can be es-
imated for each event, and so it is easier to achieve a good fit to
bserved data. Approach 2) uses a two-stage process to estimate
ime-to-event parameters for each event, and so it ismoredifficult to
nsure a good fit between observed and estimated event rates. The
atter approach, however, provides a more accurate description of
he uncertainty around the mean time-to-event parameter values
ecause the times to the different events are jointly estimated.
Best practices
IV-10 Where feasible, when estimating times to competing events,
methods of analysis that estimate the timing of competing events
jointly are preferred to approaches that estimate separate time to
event curves for each event.Representing continuous disease parameters
In some cases, the likelihood of discrete events is a function of the
value of a continuous measure (e.g., diabetic complications are a
function of Hb A1c, or clinical presentation is a function of tumor
size), as described in themodel structure and design section. Time
checks can be used to sample the likelihood of discrete events,
conditional on the status of the continuous measure of disease
progression (e.g., monthly time checks to update Hb A1c levels and
define related probabilities of complications).
Alternatively, it may be possible to define joint probability distri-
butions that represent the combined likelihoods of disease progres-
sion and related events. In the diabetes example, we might sample
the Hb A1c level at which the first complication occurs, and then
sample the time at which a patient reaches that level. This latter
approach maintains a key asset of DES, namely, that time moves
forward when the next event occurs, not in fixed time cycles.
Best practices
IV-11 Where possible, progression of continuous disease parameters
and the likelihood of related events should be defined jointly to main-
tain the discrete event nature of DES (e.g., sample the continuous
measure at which an event occurs, and then sample the time at which
that level is reached).
Model Implementation
Implementation involves transferringadefinedstructure intoacom-
puter program,which can be populated and analyzed. DES generally
represents complex systems, and their implementation requires
some formof programming. It is important to ensure that the imple-
mentation promote transparency and efficient analyses. Implemen-
tations typically consist of Read Data, Create Entities (e.g., patients),
Main Section, Remove Entities, and Present Results. The Main Sec-
tion contains the logic for the events, resource utilization and queu-
ing, risk updating, and anything else that happens during the simu-
lation.
Consider using submodels
The use of submodels facilitates transparency by grouping related
model logic (code), which can be reviewed sequentially. Examples
include departments within a hospital (where the full system is
the whole hospital) or the course of specific events such as myo-
cardial infarction and stroke (where the full system is the course of
cardiovascular disease).
The same model may be used to evaluate similar systems in
different jurisdictions (e.g., different hospitals or countries), and
data available to populate the different versions may vary (e.g.,
microcosting data may be available in one country, but only
higher-level data in another). Separate submodels can be defined
that facilitate the use of alternative forms of inputs.
Submodels also mean less code, making the model easier to de-
bug (eachsubmodel canbe tested separately, and identical codedoes
not need to be verified in multiple instances). They also ensure that
changes to the model will be consistently implemented for all strat-
egies and facilitate updating as new information becomes available.
Best practices
IV-12 To simplify debugging and updating, sub-models should be used
to structure the model. When comparing strategies within the same
system, sub-models common to all strategies should be defined once
and called from each strategy.
825V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 8 2 1 – 8 2 7Defining multiple model structures
Uncertainty around the model structure warrants implementa-
tion and analysis of alternative structures (i.e., structural sensitiv-
ity analysis). Rather than implementing separate models for each
structure, alternative structures can be implementedwithin a sin-
gle DES, reducing programming errors, as common code can be
referenced by all structures. The use of a singlemodel also reduces
nuisance variance acrossmodel structures (e.g., through the use of
common random numbers for shared submodels).
Best practices
IV-13 For structural sensitivity analyses, alternative structures should
be implemented within a single DES.
Avoiding blocking events
A common implementation error is to inadvertently block the pos-
sibility of events occurring (e.g., patients at risk of strokemay have
this “suspended” while in hospital following an admission for an-
other event).
Best practices
IV-14 Analysts should ensure that ongoing risks remain active over the
relevant time horizon.
Only collect outputs that are required
The manner in which a model is implemented determines the
range and level of outputs that can be used in the validation and
final analyses. If in modeling a clinic’s operation, the interest is in
the distribution of waiting times across individuals, it is necessary
to implement the model so that each entity holds in its attributes
a record of its waiting times. Individual-level recording is not re-
quired if the interest is only in the mean, and complexity can be
reduced by using global variables to collect values.
Best practices
IV-15 Implementation should account only for the outputs required for
validation and final analyses. If individual-level data are required,
outputs should be stored as attributes; otherwise, aggregated values
should be collected.
General programming or dedicated DES software
Most DES models are implemented by using either a general pro-
gramming language (e.g., C, R, or Fortran) or software devel-
oped specifically for DES. A general programming language pro-
vides increased flexibility, faster execution, and less dependence
on proprietary software, but it requireswriting code for basic func-
tions (e.g., to administer the event list, run queues, manage re-
sources, and sample from probability distributions), is more com-
plex, requires extensive debugging, and lacks transparency. For
many general programming languages, there are code libraries to
assist withmany basic functions, which can significantly improve
coding efficiency and debugging.
Dedicated DES software is designed to overcome the limita-
tions of general programming languages. They typically offer an
attractive, easy-to-use interface that providesmost of the required
functions (i.e., entry points, queues, events, etc.) as modules read-
ily incorporated in the model, with the code required to imple-
ment them integrated within. Time, event lists, and other basic
tasks are taken care of automatically. Common graphical user in-
terface conventions are utilized to ease use and transparency.
Many of the software incorporate animation, which renders the
model more visual and understandable. These features also facil-itate debugging and greatly increase programming efficiency—the
trade-off is somewhat reduced flexibility and calculation speed.
Spreadsheets are sometimes preferred because they are per-
ceived to bewidely understood and it is felt that this increases trans-
parency. As a spreadsheet’s core idea is to calculate everything
simultaneously, implementing the sequential nature DES and record-
ing themovement of time is awkward.Moreover, spreadsheets rapidly
growincomplexityanddiminishintransparency.Theyoffer fewready-
built tools for creating, running, or displaying a DES and programming
in an accompanying language (such as VBA) defeats the purpose of us-
ing thewidely understood spreadsheet format.
Best practices
IV-16 The choice between using general programming or dedicated DES
software should be informed by the relative importance of flexibility
and execution speed (the former) vs. modeling efficiency, automated
structure and transparency (the latter).
Analysis
Asinglemodel run estimates the outputs associatedwith a single set
of input parameters. Outputs may include mean values or distribu-
tions of values. The distribution of valueswithin amodel runmay be
of interest when evaluating systems such as a clinic, to estimate the
proportion who waits more than a certain time before being seen.
Mean values are commonly of interest for health technology assess-
ments (HTAs), where interest is in mean costs and outcomes.
The stability of the means or output distributions can be im-
proved by either running more entities or increasing the time ho-
rizon. In systems where the number of entities is sampled (e.g.,
patients presenting at a clinic) and the time horizon is fixed (e.g.,
daily operation of clinic), multiple replications using the same in-
puts can be run. Undertaking more replications will reduce vari-
ability. One model run can consist of multiple replications.
Best practices
IV-17 Analysts should test the stability of outputs generated by simi-
larly specified model runs using alternative random number seeds to
perform several independent runs and identify the number of entities,
replication duration, or number of replications (using the same inputs)
required to ensure that the distribution of outputs is stable (e.g. less
than a 5% or 1% difference between output values across model runs).
Optimizing analyses
Multiplemodel runs, using alternative inputs, are undertaken to rep-
resent uncertainty around outputs. In addition, many runs will be
undertakenduring calibrationor validation. Theseaspects of analyz-
ing DES can lead to lengthy running times. A general option is to seek
extended computing resources that facilitate parallel runs acrossmul-
tipleprocessors. Lacking sufficient computing resources, it is important
to ensure the analytic efficiency of DES by using the following:
1. Variance reduction techniques
2. Planned or algorithmic search strategies to identify input
values and a restricted set of strategies
3. The optimal balance between accuracy and number of runs
4. Meta-models to analyze the behavior of complex models
Model runs can be shortened by minimizing unwanted differences
between alternative strategies being evaluated [7]. A good starting
point is to use identical populations for each alternative. Despite
starting with identical populations, nuisance variance is introduced
by entities experiencing different pathways because of the diver-
gence of selected random numbers. The application of separate
streams of common random numbers to different events (e.g., one
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stay) helps reduce the possibility that different randomnumbers are
selected for thesameeventby thesamepatientunderdifferent strat-
egies. Using common random numbers is additionally useful in de-
bugging: the analyst can check that the time to an event not influ-
enced by the strategy is identical for the same simulated patient
across strategies. Other more sophisticated techniques, such as sig-
naling between populations to resynchronize their experience, can
be implemented, thus further reducing the requiredcomputing time.
Best practices
IV-18 Use of variance reduction techniques is recommended. Balance
should be sought between using simple techniques such as extending
model runs or matching baseline characteristics, and more sophisticated
methods available in dedicated DES software or requiring coding in more
generic software. The balance trades-off coding time versus improve-
ments in run times and results’ accuracy.
Factorial design is recommended when there are multiple di-
mensions to each factor and one can reasonably conceive of “high”
and “low” (or “on” and “off”) values for each factor defining a strat-
egy. If a DES is evaluating a continuum of options (e.g., the level of
cholesterol above which an intervention might be utilized) or
there are multiple dimensions to alternative options (e.g., several
staffing options for many staff categories), then it can become
infeasible to test every possible option [37]. The aim is to under-
stand how the output is related to the multiple factors. Instead of
using one-way sensitivity analysis on the k factors, the factorial
approach runs the model with each factor at either its “high” or
“low” level (i.e., a total of 2k model runs). This provides estimates
of each factor’s main effect and of interactions between factors.
When k is large, this can become prohibitive (e.g., 215  32,768
uns), suggesting the use of “fractional factorial design,” where
nly a subset of the 2k design points is used [38].
Optimum seeking approaches are useful when the decision
aker is interested in identifying the optimal strategy across many
ptions. This uses iterative algorithms to assess outputs for the cur-
ent configuration of options relative to a previously analyzed set,
hich, in turn, informs the next set of options to evaluate [32]. This
terative process is continued until a specified “stopping rule” is
chieved (e.g., a specific number of iterations or some “tolerance
evel” for improvement in output response). There are many meth-
ds that can be used to decide on the next configuration to evaluate,
ncludingmoving a certain number of steps in the direction inwhich
erformance appears to be improving and using random jumps to
void local optima. Such approaches are standard in the field of op-
imization and often save substantial analyst and computer time.
Handling uncertainty around inputs is an additional process
hat can be done by a series of runs by using alternative inputs
either deterministically or probabilistically). Running times for
robabilistic sensitivity analysis can be large due to the combined
equirement to reduce the variance around each run’s outputs and
o undertake multiple runs. Rather than abandon probabilistic
ensitivity analysis altogether, formulae based on analysis of vari-
nce can be used to estimate the combined run size and the num-
er of model runs required to optimize the precision of the out-
uts, given an available (or desired) analytic time [39].
Meta-modeling involves running a DESwith different inputs and
hen using regressionmethods to obtain an equation estimating the
utputs as a function of the inputs [40]. The selection of configura-
ions to run canbe informedby factorial design, and themeta-model
an, in turn, be used to inform and speed up factorial design and
ptimumseeking approaches. Gaussianprocess emulators have been
sed inhealth economic simulations andhave the advantage that out-
ut uncertainty can be represented for configurations not within the
valuated set, which enables quicker computation of probabilistic sen-
itivity analysis and expected value of information estimates.Best practices
IV-19 If the number of strategies to compare is large or there are many
structural assumptions to test, then factorial design and optimum
seeking approaches should be used.
IV-20 When run times for probabilistic sensitivity analysis are con-
strained, the optimal combination of run size (per input parameter set)
and numbers of alternative inputs tested should be estimated empirically to
optimize the precision of the outputs of interest.
IV-21 When computing time precludes adequate representation of all
potential strategies and parameter uncertainty, meta-modeling should
be used.
Warm-up or preload
In some decision problems, the analysis does not start with an
empty system (e.g., when simulating a hospital clinic that has
been running for a number of years, the relevant starting pointwill
be the current operation of the clinic, incorporating the patients
currently booked orwaiting). One option is to preload entitieswith
existing attributes and history of events and start collecting re-
sults for analysis immediately. Preloading is appropriate if it is
based on an empirical data set describing the current status of
entities across the system. The alternative is to run the model for
some time prior to starting the analysis—a “warm-up” period.
From empty at the beginning of thewarm-up period, the system is
built up to the current state on the basis of inputs that will con-
tinue to be applied within the main analysis.
An important advantage of using a warm-up period is that it
helps validate the model by testing whether it is able to create real-
istic starting conditions. The process ofmatching current conditions
can be difficult, however, if inputs have changed over time (e.g., as a
result of shifting referral patterns or the introductionofnew technol-
ogies). In such cases, the application of constant values will misrep-
resent the values to be applied within the main analysis.
Outputs generated during the warm-up phase may vary from
those in themain analysis, and these provide another opportunity
for model validation.
Best practices
IV-22 If the system to be modeled is not empty at the start of the time
horizon to be evaluated, a warm-up period should be used to build the
system up to the starting point provided:
● it can be reasonably assumed that the key parameters have re-
mained constant over time or
● the history of the key parameters can be incorporated into the
warm-up period.
Otherwise, creating starting entities with ready-made histories
(“preloading”) is acceptable.
Representing and Reporting Des
Animation
Dedicated DES software often facilitates animated representation
of models, where the key events are displayed with the passage of
entities between them. Humans are better at recognizing pattern
andproblematicmovement visually than via analysis of equations
or data. Animation plays to this strength, enabling the identifica-
tion of illogical movements in the model. It also provides for face
validation, where content experts can review the structure of the
model and the movement of entities.
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IV-23 Animated representation that displays the experience of events by
individuals is recommended as a means of engaging with users and helping
to debug through identification of illogical movements.
Diagrams
Reports of DES should include diagrams that help the readers un-
derstand their structure and function. Flow diagrams or state
charts provide general frameworks for representing key elements,
including possible pathways between events (logic and causal re-
lationships) and presence of queues and decision points. More
detailed representations of the structure should enable the read-
ers to replicate the model (if they so wish). Module or event docu-
mentation figures can be used to describe the actions undertaken
before, during, and after each event. Lists of variables and attri-
butes used and when they are updated provide the user with a
detailed understanding of the underlying process.
Best practices
IV-24 Both general and detailed representations of a DES structure and
logic should be reported to cover the needs of different users. Detailed
event documentation figures are also of benefit to the modeler when
returning to the model after a period of absence.
Conclusion
DES provides a flexible framework that can be used to model a wide
variety of health careproblems. Since it facilitates the representation
of complex systems, there are a range of issues along the model
development, parameter estimation, implementation, analysis, and
reporting spectrum that should be addressed tomaximize the value
of the finalmodel and its associated outputs. This article has reviewed
themain components of themodeling process andprovided best prac-
tice recommendations that should, if followed, increase the validity,
transparency, and value of DES applied in a health care context.
Source of financial support: This Task Force was supported by
ISPOR.
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